None
Quote | Chi Mei Optoelectronics Corp Sponsored Reg S GDR (OTCMKTS:CMOPF)
Last: | $76 |
---|---|
Change Percent: | 0.0% |
Open: | $76 |
Close: | $76 |
High: | $76 |
Low: | $76 |
Volume: | 100 |
Last Trade Date Time: | 04/11/2024 03:00:00 am |
News | Chi Mei Optoelectronics Corp Sponsored Reg S GDR (OTCMKTS:CMOPF)
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024. Current CEO Alessandro Della Chà to be appointed as new Chairman of the Board. Incumbent Chairman Mauro Ajani to continue as a Board member. Additional Boar...
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence...
Message Board Posts | Chi Mei Optoelectronics Corp Sponsored Reg S GDR (OTCMKTS:CMOPF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Chi Mei Optoelectronics Corp Sponsored Reg S GDR Company Name:
CMOPF Stock Symbol:
OTCMKTS Market:
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024. Current CEO Alessandro Della Chà to be appointed as new Chairman of the Board. Incumbent Chairman Mauro Ajani to continue as a Board member. Additional Boar...
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence...
Ad hoc announcement pursuant to Art. 53 LR Medtronic deal accounted in 2024, to inject USD 200m cash. FDA approval of GI Genius new enhanced operating system. New GI drug development program announced. Outlook for 2025. Dublin, Ireland--(Newsfile Corp. - March 20, 2024) - Cosm...